Dr. Charles E. Hergesheimer, MD

Dr. Hergesheimer practices at UC San Diego Health Community Group in Vista, California.

Dr. Hergesheimer's NPI, 1508892860, was assigned on June 25, 2006. Dr. Hergesheimer graduated from UC Irvine School of Medicine in 1991. Dr. Hergesheimer holds California license G76058.

Dr. Hergesheimer's primary practice is UC San Diego Health Community Group, at 910 Sycamore Ave, Vista, CA 92081 in San Diego County. The practice phone is (858) 249-5908.

Dr. Hergesheimer's primary practice is UC San Diego Health Community Group in Vista, California. Dr. Hergesheimer is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Hergesheimer to 1 more hospital, 5 home health agencies, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hergesheimer practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hergesheimer's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Hergesheimer is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hergesheimer is licensed in California.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute skin infection, adjustment disease, alzheimer's disease, aneurysm, aortic atherosclerois and arteritis among the conditions Dr. Hergesheimer treats.

CMS data shows 4,503 Medicare services from Dr. Hergesheimer across 20 procedure codes in 2024, for 494 Medicare patients. Medicare paid $119,323 for them. Every service was in an office.

CMS counts 494 Medicare patients who saw Dr. Hergesheimer in 2024. The largest group is 75 to 84, with 210 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hergesheimer's median patient age at 73, with 47% women.

In 2024, Dr. Hergesheimer wrote 8,787 Medicare Part D claims for 707 patients. 87% of them were for generic drugs. CMS names the drug for 7,946 of them, across 162 drugs with 11 or more claims each, at $795,617 in total drug cost. In 2023, CMS named 7,634 claims across 166 drugs.

Dr. Hergesheimer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hergesheimer as offering telehealth. CMS counts 22 procedures of removal of skin lesions by Dr. Hergesheimer, more than 66% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 18 general payments to Dr. Hergesheimer from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Astellas Pharma US Inc paid the most, $35.

Dmand AI lists 2 awards for Dr. Hergesheimer, most recently CMS Stage 1 EHR in 2013.

Dr. Hergesheimer graduated from UC Irvine School of Medicine in 1991. Dr. Hergesheimer is a member of AOA and ACP.

Dr. Hergesheimer is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.